Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;38(10):1105-1114.
doi: 10.1007/s10654-023-01024-1. Epub 2023 Jun 15.

Target trial emulation of aspirin after diagnosis of colorectal polyps

Louise Emilsson  1   2   3   4 , Mingyang Song  5   6   7 , Jonas F Ludvigsson  8   9   10
Affiliations

Target trial emulation of aspirin after diagnosis of colorectal polyps

Louise Emilsson et al. Eur J Epidemiol. 2023 Oct.

Abstract

Backgound and aims: Previous research on the potential chemoprotective effect of aspirin for colorectal cancer (CRC) shows conflicting results. We aimed to emulate a trial of aspirin intiation in individuals with incident polyps.

Methods: We identified individuals registered with their first colorectal polyp in the nationwide gastrointestinal ESPRESSO histopathology cohort in Sweden. Individuals aged 45-79 years diagnosed with colorectal polyps 2006-2016 in Sweden without CRC or contraindications for preventive aspirin (cerebrovascular disease, heart failure, aortic aneurysms, pulmonary emboli, myocardial infarction, gastric ulcer, dementia, liver cirrhosis, or any other metastatic cancer) registered until the month of first polyp detection were eligible. Using duplication and inverse probability weighting, we emulated a target trial of aspirin initiation within 2 years of initial polyp detection. The main outcome measures were incident CRC, CRC mortality and all-cause mortality registered until 2019.

Results: Of 31,633 individuals meeting our inclusion criteria, 1716 (5%) initiated aspirin within 2 years of colon polyp diagnosis. Median follow-up was 8.07 years. The 10-year cumulative incidence in initiators versus non-initiators was 6% versus 8% for CRC incidence, 1% versus 1% for CRC mortality and 21% versus 18% for all-cause mortality. The corresponding hazard ratios were 0.88 (95% confidence interval, 95%CI = 0.86-0.90), 0.90 (95%CI = 0.75-1.06) and 1.18 (95%CI = 1.12-1.24).

Conclusion: Aspirin initiation in individuals with polyp removal was linked to 2% lower cumulative incidence of CRC after 10 years but did not alter CRC mortality. We also observed a 4% increased risk difference of all-cause mortality at 10 years after the initiation of aspirin.

Keywords: Cancer prevention; Causal inference; Precision medicine; Target trial emulation.

PubMed Disclaimer

Conflict of interest statement

Dr. Ludvigsson has coordinated a study unrelated to the present study on behalf of the Swedish IBD Quality Register (SWIBREG). That study received funding from Janssen. Authors not named here have disclosed no conflicts of interest.

Figures

Fig. 1
Fig. 1
Participant flowchart. CRC, colorectal cancer. CVD, cardiovascular disease. TIA, Transient ischemic attack. The 1,042 individuals in the aspirin arm not initiating or being artificially censored reached end of follow-up within months 1–23
Fig. 2
Fig. 2
Colorectal cancer (CRC) incidence and CRC cancer mortality standardized to baseline variables
Fig. 3
Fig. 3
All-cause mortality in those aged < 66 years and all participants
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696. doi: 10.1056/NEJMoa1100370. - DOI - PMC - PubMed
    1. Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. 2014;312(6):606–615. doi: 10.1001/jama.2014.8266. - DOI - PMC - PubMed
    1. Song M, Emilsson L, Bozorg SR, et al. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study. Lancet Gastroenterol Hepatol. 2020;5(6):537–547. doi: 10.1016/s2468-1253(20)30009-1. - DOI - PMC - PubMed
    1. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741–1750. doi: 10.1016/S0140-6736(10)61543-7. - DOI - PubMed

LinkOut - more resources